Cargando…

Midregional pro-atrial natriuretic peptide is a superior biomarker to N-terminal pro-B-type natriuretic peptide in the diagnosis of heart failure patients with preserved ejection fraction

OBJECTIVES: To explore that if mid-regional sequence of pro-A-type natriuretic peptide (MR-proANP) may have a good value of diagnosis in heart failure with preserved ejection fraction (HFpEF) compared with N-terminal pro-B-type natriuretic peptide (NT-proBNP). METHODS: Participants with cardiovascul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cui, Kun, Huang, Wei, Fan, Jinqi, Lei, Han
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6133645/ https://www.ncbi.nlm.nih.gov/pubmed/30200170 http://dx.doi.org/10.1097/MD.0000000000012277

Ejemplares similares

Midregional pro-atrial natriuretic peptide, an important member of the natriuretic peptide family: potential role in diagnosis and prognosis of cardiovascular disease
por: Idzikowska, Karolina, et al.
Publicado: (2018)

Efficacy of exogenous atrial natriuretic peptide in patients with heart failure with preserved ejection fraction: deficiency of atrial natriuretic peptide and replacement therapy
por: Matsumoto, Shingo, et al.
Publicado: (2020)

Midregional pro atrial natriuretic peptide: a novel important biomarker for noise annoyance-induced cardiovascular morbidity and mortality?
por: Hahad, Omar, et al.
Publicado: (2020)

N-terminal Pro-Brain Natriuretic Peptide And Atrial Fibrillation
por: Thejus, Jayachandran, et al.
Publicado: (2009)

N‐terminal pro‐B‐type natriuretic peptide testing patterns in patients with heart failure with reduced ejection fraction
por: Januzzi, James L., et al.
Publicado: (2021)

Plasma atrial natriuretic peptide and N-terminal pro B-type natriuretic peptide concentrations in dogs with right-sided congestive heart failure
por: KANNO, Nobuyuki, et al.
Publicado: (2015)

N‐Terminal Pro Brain, N‐Terminal Pro Atrial Natriuretic Peptides, and Dynamic Cerebral Autoregulation
por: Mahinrad, Simin, et al.
Publicado: (2020)

Utility of point-of-care testing of natriuretic peptides (brain natriuretic peptide and n-terminal pro-brain natriuretic peptide) in the emergency department
por: Nayer, Jamshed, et al.
Publicado: (2014)

Midregional pro-Adrenomedullin in addition to b-type natriuretic peptides in the risk stratification of patients with acute dyspnea: an observational study
por: Potocki, Mihael, et al.
Publicado: (2009)

Patients with heart failure with preserved ejection fraction and low levels of natriuretic peptides
por: Meijers, W. C., et al.
Publicado: (2016)

Relationship of atrial fibrillation and N terminal pro brain natriuretic peptide in heart failure patients
por: Nasab Mehrabi, Entezar, et al.
Publicado: (2023)

Impact of Midregional N‐Terminal Pro–Atrial Natriuretic Peptide and Soluble Suppression of Tumorigenicity 2 Levels on Heart Rhythm in Patients Treated With Catheter Ablation for Atrial Fibrillation: The Biorhythm Study
por: Badoz, Marc, et al.
Publicado: (2021)

Highest Obesity Category Associated With Largest Decrease in N‐Terminal Pro‐B‐Type Natriuretic Peptide in Patients Hospitalized With Heart Failure With Preserved Ejection Fraction
por: Vaishnav, Joban, et al.
Publicado: (2020)

Midregional-proAtrial Natriuretic Peptide and High Sensitive Troponin T Strongly Predict Adverse Outcome in Patients Undergoing Percutaneous Repair of Mitral Valve Regurgitation
por: Wöhrle, Jochen, et al.
Publicado: (2015)

Effects of glutamine and valsartan on the brain natriuretic peptide and N-terminal pro-B-type natriuretic peptide of patients with chronic heart failure
por: Shao, Mingliang, et al.
Publicado: (2015)

Effect of Pancreatic Hormones on pro-Atrial Natriuretic Peptide in Humans
por: Zois, Nora E., et al.
Publicado: (2017)

Artificial Intelligence-Enabled Electrocardiography Detects B-Type Natriuretic Peptide and N-Terminal Pro-Brain Natriuretic Peptide
por: Liu, Pang-Yen, et al.
Publicado: (2023)

Marked elevation of B-type natriuretic peptide in patients with heart failure and preserved ejection fraction
por: Tate, Samuel, et al.
Publicado: (2014)

Natriuretic Peptide Levels and Stages of Left Ventricular Dysfunction in Heart Failure with Preserved Ejection Fraction
por: Dal Canto, Elisa, et al.
Publicado: (2023)

NH(2)-Terminal Pro–Brain Natriuretic Peptide and Risk of Diabetes
por: Lazo, Mariana, et al.
Publicado: (2013)

N-terminal pro brain natriuretic peptide in coronary artery disease
por: Tin, Sim Sai, et al.
Publicado: (2015)

N-Terminal Pro–B-Type Natriuretic Peptide and Incident CKD
por: Sasaki, Takaya, et al.
Publicado: (2021)

Factors Associated With Elevated N-Terminal Pro B-Type Natriuretic Peptide Concentrations at the Convalescent Stage and 1-Year Outcomes in Patients With Heart Failure With Preserved Ejection Fraction
por: Oeun, Bolrathanak, et al.
Publicado: (2020)

Plasma N-terminal pro-atrial natriuretic peptide concentrations are affected by dehydration in healthy dogs
por: Ogawa, Mizuki, et al.
Publicado: (2023)

Correlation between B-type natriuretic peptide and N-terminal pro-brain natriuretic peptide in patients presenting to an emergency department with decompensated heart failure
por: Villacorta, H, et al.
Publicado: (2005)

Evolution of B-type natriuretic peptide and N-terminal pro-brain natriuretic peptide during acute decompensated heart failure in a chronic heart failure patient with reduced ejection fraction treated with Sacubitril/Valsartan: a case report
por: Tiepolo, Ambre, et al.
Publicado: (2019)

Glucagon-like peptide-1: effect on pro-atrial natriuretic peptide in healthy males
por: Skov, Jeppe, et al.
Publicado: (2014)

N‐terminal pro brain natriuretic peptide eliminates the prognostic effect of atrial fibrillation in patients with chronic heart failure
por: Schnorbach, Johannes, et al.
Publicado: (2019)

Diagnostic and prognostic values of B-type natriuretic peptides (BNP) and N-terminal fragment brain natriuretic peptides (NT-pro-BNP)
por: Maries, Lorena, et al.
Publicado: (2013)

Intensive Lifestyle Intervention Increases Plasma Midregional Proatrial Natriuretic Peptide Concentrations in Overweight Children
por: Thomsen, Camilla F., et al.
Publicado: (2021)

The Importance of Amino-terminal pro-Brain Natriuretic Peptide Testing in Clinical Cardiology
por: Kimmenade, Van, et al.
Publicado: (2007)

Reply to: N-terminal pro brain natriuretic peptide in coronary artery disease
por: Radwan, Hanan, et al.
Publicado: (2015)

N‐Terminal Pro‐C‐Natriuretic Peptide and Cytokine Kinetics in Dogs with Endotoxemia
por: Floras, A.N.K., et al.
Publicado: (2014)

Levels of N-terminal pro-brain natriuretic peptide in brain injury patients
por: Tsentsiper, L, et al.
Publicado: (2015)

N-terminal Pro-B-Type Natriuretic Peptide and Malnutrition in Patients on Hemodialysis
por: Ducros, Jacques, et al.
Publicado: (2020)

Discriminative Utility of Apelin-to-NT-Pro-Brain Natriuretic Peptide Ratio for Heart Failure with Preserved Ejection Fraction among Type 2 Diabetes Mellitus Patients
por: Berezin, Alexander A., et al.
Publicado: (2022)

N-terminal pro atrial natriuretic peptide as a prognostic marker of cardiac resynchronization therapy recipients
por: Ueda, Nobuhiko, et al.
Publicado: (2023)

Prognostic value of pro-atrial natriuretic peptide, pro-adrenomedullin, and pro-endothelin-1 in critically ill patients
por: Bloos, F, et al.
Publicado: (2006)

B-type natriuretic peptide and N-terminal Pro-B-type natriuretic peptide in severe aortic stenosis: a comprehensive literature review
por: Cavalcante, Pâmela Nogueira, et al.
Publicado: (2023)

B-type natriuretic peptide versus amino terminal pro-B type natriuretic peptide: selecting the optimal heart failure marker in patients with impaired kidney function
por: Jafri, Lena, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_85d86qaoe8arpi8etohufct1qk